Fresenius | FRE - Net Income


Fresenius reported EUR361M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Akzo Nobel EUR 139M 46M Jun/2026
Alcon AG USD 189M 28M Mar/2026
AstraZeneca USD 2.51B 573M Jun/2026
BASF EUR 4.14B 3.22B Jun/2026
Bayer EUR 2.76B 6.52B Mar/2026
Beiersdorf EUR 387M 165M Dec/2025
DaVita Healthcare Partners USD 197.53M 36.69M Mar/2026
Demant DKK 427M 690M Dec/2025
E.ON EUR 2.23B 1.41B Mar/2026
Essilor EUR 1.57B 638M Jun/2026
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 118M 209M Mar/2026
Getinge SEK 839M 177M Jun/2026
Givaudan CHF 479M 113M Dec/2025
GlaxoSmithKline GBP 435M 1.3B Jun/2026
GN Store Nord DKK -955M 1.3B Mar/2026
GRIFOLS EUR 154M 81M Jun/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Lonza CHF 426M 119M Jun/2025
Merck EUR 659M 340M Mar/2026
Novartis USD 3.26B 108M Jun/2026
Philips EUR 384M 233M Jun/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
RWE EUR 20M 811M Mar/2026
Sanofi EUR 343M 1.27B Jun/2026
Smith & Nephew USD 293M 79M Dec/2025